757 related articles for article (PubMed ID: 19349716)
1. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model.
Bilgili H; Kosar A; Kurt M; Onal IK; Goker H; Captug O; Shorbagi A; Turgut M; Kekilli M; Kurt OK; Kirazli S; Aksu S; Haznedaroglu IC
Med Princ Pract; 2009; 18(3):165-9. PubMed ID: 19349716
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper.
Haznedaroglu BZ; Haznedaroglu IC; Walker SL; Bilgili H; Goker H; Kosar A; Aktas A; Captug O; Kurt M; Ozdemir O; Kirazli S; Firat HC
Clin Appl Thromb Hemost; 2010 Aug; 16(4):446-53. PubMed ID: 19833624
[TBL] [Abstract][Full Text] [Related]
4. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability.
Kurt M; Oztas E; Kuran S; Onal IK; Kekilli M; Haznedaroglu IC
Am J Emerg Med; 2009 Jun; 27(5):631.e1-2. PubMed ID: 19497484
[TBL] [Abstract][Full Text] [Related]
5. Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model.
Tokgöz H; Karakaya K; Hanci V; Abduşoğlu M; Erol B; Türksoy O; Akduman B; Mungan NA
Urology; 2010 Jun; 75(6):1515.e9-14. PubMed ID: 20223504
[TBL] [Abstract][Full Text] [Related]
6. First clinical experience of Ankaferd BloodStopper as a hemostatic agent in partial nephrectomy.
Huri E; Akgül T; Ayyildiz A; Bağcioğlu M; Germiyanoğlu C
Kaohsiung J Med Sci; 2010 Sep; 26(9):493-5. PubMed ID: 20837346
[TBL] [Abstract][Full Text] [Related]
7. The hemostatic efficacy of Ankaferd Blood Stopper in adenoidectomy.
Iynen I; Bozkus F; San I; Alatas N
Int J Pediatr Otorhinolaryngol; 2011 Oct; 75(10):1292-5. PubMed ID: 21813191
[TBL] [Abstract][Full Text] [Related]
8. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy.
Teker AM; Korkut AY; Gedikli O; Kahya V
Int J Pediatr Otorhinolaryngol; 2009 Dec; 73(12):1742-5. PubMed ID: 19836089
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hemostatic effects of Ankaferd as an alternative medicine.
Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC
Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial.
Huri E; Akgül T; Ayyildiz A; Ustün H; Germiyanoğlu C
J Urol; 2009 May; 181(5):2349-54. PubMed ID: 19303089
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage.
Ward KR; Tiba MH; Holbert WH; Blocher CR; Draucker GT; Proffitt EK; Bowlin GL; Ivatury RR; Diegelmann RF
J Trauma; 2007 Aug; 63(2):276-83; discussion 283-4. PubMed ID: 17693824
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration.
Karakaya K; Ucan HB; Tascilar O; Emre AU; Cakmak GK; Irkorucu O; Ankarali H; Comert M
J Invest Surg; 2009; 22(3):201-6. PubMed ID: 19466658
[TBL] [Abstract][Full Text] [Related]
13. The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding.
Koyuncu N
Adv Ther; 2019 May; 36(5):1143-1149. PubMed ID: 30900196
[TBL] [Abstract][Full Text] [Related]
14. Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues.
Okumuş M; Yüksel KZ; Özbağ D; Çıralık H; Yılmaz Z; Gümüşalan Y; Bakan V; Kalender AM
Ulus Travma Acil Cerrahi Derg; 2013 Jan; 19(1):1-7. PubMed ID: 23588971
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model.
Iynen I; Sogut O; Kose R
Otolaryngol Head Neck Surg; 2011 Nov; 145(5):840-4. PubMed ID: 21750339
[TBL] [Abstract][Full Text] [Related]
16. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract.
Kurt M; Kacar S; Onal IK; Akdogan M; Haznedaroglu IC
Endoscopy; 2008 Sep; 40 Suppl 2():E262. PubMed ID: 19090459
[No Abstract] [Full Text] [Related]
17. New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor.
Öner AF; Doğan M; Kaya A; Sal E; Bektaş MS; Yesilmen O; Ayhan H; Acikgoz M
Clin Appl Thromb Hemost; 2010 Dec; 16(6):705-7. PubMed ID: 19528064
[TBL] [Abstract][Full Text] [Related]
18. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis.
Leblebisatan G; Bay A; Karakus SC; Kekilli M; Haznedaroglu IC
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):494-7. PubMed ID: 22576286
[TBL] [Abstract][Full Text] [Related]
19. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience.
Baykul T; Alanoglu EG; Kocer G
J Contemp Dent Pract; 2010 Jan; 11(1):E088-94. PubMed ID: 20098971
[TBL] [Abstract][Full Text] [Related]
20. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine.
Kheirabadi BS; Scherer MR; Estep JS; Dubick MA; Holcomb JB
J Trauma; 2009 Sep; 67(3):450-9; discussion 459-60. PubMed ID: 19741385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
